BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33025887)

  • 1. One year in review 2020: pathogenesis of primary Sjögren's syndrome.
    Bombardieri M; Argyropoulou OD; Ferro F; Coleby R; Pontarini E; Governato G; Lucchesi D; Fulvio G; Tzioufas AG; Baldini C
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):3-9. PubMed ID: 33025887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One year in review 2019: Sjögren's syndrome.
    Cafaro G; Croia C; Argyropoulou OD; Leone MC; Orlandi M; Finamore F; Cecchettini A; Ferro F; Baldini C; Bartoloni E
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):3-15. PubMed ID: 31464675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One year in review 2018: Sjögren's syndrome.
    Argyropoulou OD; Valentini E; Ferro F; Leone MC; Cafaro G; Bartoloni E; Baldini C
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):14-26. PubMed ID: 30156536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren's syndrome: one year in review 2022.
    Manfrè V; Chatzis LG; Cafaro G; Fonzetti S; Calvacchi S; Fulvio G; Navarro Garcia IC; La Rocca G; Ferro F; Perricone C; Bartoloni E; Baldini C
    Clin Exp Rheumatol; 2022 Dec; 40(12):2211-2224. PubMed ID: 36541236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One year in review 2017: primary Sjögren's syndrome.
    Ferro F; Marcucci E; Orlandi M; Baldini C; Bartoloni-Bocci E
    Clin Exp Rheumatol; 2017; 35(2):179-191. PubMed ID: 28337967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies.
    Thorlacius GE; Björk A; Wahren-Herlenius M
    Nat Rev Rheumatol; 2023 May; 19(5):288-306. PubMed ID: 36914790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on disease pathogenesis, diagnosis, and management of primary Sjögren's syndrome.
    Wang J; Zhou L; Liu B
    Int J Rheum Dis; 2020 Jun; 23(6):723-727. PubMed ID: 32297483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights of the 14th International Symposium in Sjögren's Syndrome.
    Bombardieri M; Baldini C; Alevizos I; Akpek E; Baer AN
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):3-13. PubMed ID: 30156541
    [No Abstract]   [Full Text] [Related]  

  • 9. It's not the same old lupus or Sjögren's any more: one hundred new insights, approaches, and options since 1990.
    Wallace DJ; Linker-Israeli M
    Curr Opin Rheumatol; 1999 Sep; 11(5):321-9. PubMed ID: 10503650
    [No Abstract]   [Full Text] [Related]  

  • 10. Sjögren's syndrome: one year in review 2023.
    Longhino S; Chatzis LG; Dal Pozzolo R; Peretti S; Fulvio G; La Rocca G; Navarro Garcia IC; Orlandi M; Quartuccio L; Baldini C; Bartoloni E
    Clin Exp Rheumatol; 2023 Dec; 41(12):2343-2356. PubMed ID: 38149515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alterations in primary Sjögren's syndrome - an overview.
    Imgenberg-Kreuz J; Sandling JK; Nordmark G
    Clin Immunol; 2018 Nov; 196():12-20. PubMed ID: 29649576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and epigenetics in primary Sjögren's syndrome.
    Imgenberg-Kreuz J; Rasmussen A; Sivils K; Nordmark G
    Rheumatology (Oxford); 2021 May; 60(5):2085-2098. PubMed ID: 30770922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year in review 2016: Sjögren's syndrome.
    Ferro F; Vagelli R; Bruni C; Cafaro G; Marcucci E; Bartoloni E; Baldini C
    Clin Exp Rheumatol; 2016; 34(2):161-71. PubMed ID: 27095672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Sjögren's syndrome and deficiency of ICA69.
    Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
    Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic, genomic and epigenetic studies as tools for elucidating disease pathogenesis in primary Sjögren's syndrome.
    Miceli-Richard C; Criswell LA
    Expert Rev Clin Immunol; 2014 Apr; 10(4):437-44. PubMed ID: 24646085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labial Gland Mesenchymal Stem Cell Derived Exosomes-Mediated miRNA-125b Attenuates Experimental Sjogren's Syndrome by Targeting PRDM1 and Suppressing Plasma Cells.
    Xing Y; Li B; He J; Hua H
    Front Immunol; 2022; 13():871096. PubMed ID: 35444638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sjögren's syndrome: Towards precision medicine].
    Laigle L; Le Dantec C; Soret P; Desvaux E; Hubert S; Foulquier N; Moingeon P; Guedj M; Pers JO
    Med Sci (Paris); 2022 Feb; 38(2):148-151. PubMed ID: 35179468
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sjögren's Syndrome: Early diagnosis and effective treatment].
    Witte T
    Dtsch Med Wochenschr; 2018 Dec; 143(24):1778-1782. PubMed ID: 30508859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates on Sjögren's syndrome: from proteomics to protein biomarkers.
    Baldini C; Cecchettini A; Gallo A; Bombardieri S
    Expert Rev Proteomics; 2017 Jun; 14(6):491-498. PubMed ID: 28532233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome.
    Huang YF; Cheng Q; Jiang CM; An S; Xiao L; Gou YC; Yu WJ; Lei L; Chen QM; Wang Y; Wang J
    Clin Dev Immunol; 2013; 2013():160491. PubMed ID: 23935646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.